Advamab 400 mg Injection
  1. Home
  2. Pharma Products
  3. Alkem Laboratories Ltd
  4. Advamab 400 mg Injection

Advamab 400 mg Injection

Advamab 400 mg Injection contains bevacizumab, an anticancer medicine used in the treatment of several types of cancer. It is supplied as a 400 mg/16 mL solution for intravenous infusion. The medicine works by inhibiting VEGF, which helps reduce the formation of blood vessels that support tumor growth.

BUY NOW

Category

Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor involved in tumor angiogenesis. By blocking this pathway, it can help limit the blood supply that supports cancer growth and spread. Advamab may be used as part of treatment protocols for cancers including colorectal, lung, kidney, ovarian, cervical, and certain brain cancers, depending on clinical indications. Administration and treatment monitoring should be managed by qualified healthcare professionals according to the prescribed oncology protocol.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg/16 mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 1 Vial of 16 mL
Manufacturer Alkem Laboratories Ltd

Product Also Known As

Advamab 400 mg Injection, Bevacizumab 400 mg Injection, Advamab 400 mg/16 mL Injection, Bevacizumab Solution for Infusion, Advamab Cancer Injection, Bevacizumab Anticancer Injection